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We have analyzed the effect of CD3/T-CeU receptor stimulation on GTP hydrolysis and GTP binding. We show that 
stimulation of Jurkat, T-cell, membranes with OKT3 results in a 50% increase inGTP hydrolysis which is specifically 
inhibited by GDP. Pretreatment of he membranes with neither pertussis toxin nor cholera toxin inhibited the GTP hy- 
drolysis. We also show that stimulation with OKT3 increases the binding of GTP~,S to Jurkat membranes. These data 
strongly implicate he involvement of a G-protein i  CD3/T-Cell receptor signalling. 
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1. INTRODUCTION 
G-proteins are a group of GTP hydrolysing, 
membrane associated, proteins that link receptor 
stimulation to several effectors including adenylate 
cyclase [1]. Receptors can be coupled to the 
adenylate cyclase via a stimulatory (and cholera 
toxin-sensitive) Gs-protein or via an inhibitory 
(and pertussis toxin-sensitive) Gi-protein. Recent- 
ly, the involvement of a G-protein, termed Gp, in 
the breakdown of phosphatidylinositol (PI) was 
suggested [2]. The G-protein that stimulates 
phospholipase C (PLC) can be either sensitive or 
insensitive to pertussis toxin depending on the cell 
type studied. Thus, a pertussis toxin-sensitive G- 
protein has been shown to couple the receptor for 
f-Met-Leu-Phe (fMLP) to activation of PLC in 
neutrophils [3,4] whereas the G-protein that links 
the TRH receptor on GH3 pituitary cells [5] and 
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the Ig-receptor on B-cells [6] to PLC is pertussis 
toxin-insensitive. 
The human T-cell receptor consists of the 
clonotypic antigen-specific Ti t~-~ heterodimer and 
the monomorphic CD3 complex. The CD3 com- 
plex comprises at least four, and possibly five, in- 
tegral membrane proteins and is suggested to be 
involved in transmembrane signalling following 
antigen binding to the T-cell receptor. Stimulation 
of the CD3/T-cell receptor by antigen or specific 
antibodies leads to an increased inositol phosphate 
formation and to increased intracellular Ca 2+ [7]. 
The evidence for the involvement of G-proteins in 
T-cell activation is so far only indirect. The fact 
that G-protein modulation by bacterial toxins were 
able to block T-cell activation [8,9] might be due to 
indirect action on i.e. cAMP. Similarly, the fact 
that nonhydrolysable GTP analogues in permea- 
bilized cells or cell membranes mimic cellular 
events, such as inositol phosphate formation and 
serine esterase release, involved in T-cell activation 
[10,11] is suggestive but not conclusive vidence 
since the effect could be mediated by G-proteins 
that are involved in a parallel signal transduction 
pathway. Moreover, GTP may have effects that 
are independent of membrane based G-proteins in- 
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cluding the recently reported ability to release Ca 2+ 
from intracellular stores [12]. The study of GTP  
hydrolysis or GTP  binding upon st imulation of 
specific receptors on cellular membranes appears 
to be a more direct way to investigate G-protein 
coupling to receptors. In this report we demon- 
strate that st imulation of the CD3/T-cel l  receptor 
complex results in increased hydrolysis and bind- 
ing of GTP  to T-cell membranes.  
2. EXPERIMENTAL  
2.1. Cells 
The human leukemic T-cell line, Jurkat, was maintained in 
RPMI-1640 supplemented with 7.507o fetal calf serum, l- 
glutamine and penicillin/streptomycin. 
2.2. Chemicals 
The monoclonal anti-CD3-antibody, OKT3, was from a 
hybridoma obtained from the American Type Culture Collec- 
tion (no.CRL 800) and purified on protein A-Sepharose. Per- 
tussis toxin was a kind gift from Dr Per Askel6f at Statens 
Bakteriologiska Laboratorium, Stockholm, Sweden. Cholera 
toxin was purchased from Sigma. [7-32p]GTP and [35S]GTPTS 
were purchased from NEN, DuPont. 
2.3. GTP hydrolysis assay 
Jurkat cell membranes were prepared by sonication i  25 mM 
Tris, 5 mM MgC12, 1 mM PMSF (pH 7.6). Cell debris was 
removed by centrifugation at150 x g for 5 min. The superna- 
tant was collected and soluble proteins were removed by cen- 
trifugation at 10000 × g for 10 min. The fractions were 
analysed by a 5' -nucleotidase assay as described before [13]. All 
of the nucleotidase activity remained in the membrane fraction 
demonstrating an almost complete recovery of plasma mem- 
branes (homogenate 94.2 nmol/mg per h; membrane fraction, 
418.5 nmol/mg per h and soluble fraction, 0 nmol/mg per h). 
The pellet was resuspended and protein concentration assayed. 
This crude membrane fraction was kept on ice until used. In- 
cubations were carried out at 30°C in a final volume of 100/~l. 
The reaction buffer consisted of 10 mM Tris (pH 7.8), 10 mM 
MgC12, 1 mM EDTA, 0.2070 BSA, 0.5 mM ascorbic acid, 
0.5 mM adenyl-5-yl imidodiphosphate, anATP regenerating 
system (0.1 mM ATP, 3 mM creatine phosphate and 75 U/m1 
creatine phosphokinase), 100 nM [y-32p]GTP with GDP and 
OKT3 as indicated. The reaction was started by the addition of 
20/~g of membrane protein and stopped by the addition of 
700#1 of 5070 Norit A in 0.15 M potassium phosphate buffer 
(pH 7.0). After centrifugation at10000 x g for 15 min 500 #l 
of supernatant was collected and the released 32p~ counted. 
2.4. GTP binding assay 
Binding reactions were carried out at 30°C in 50/LI of 10 mM 
Tris (pH 7.8), 10 mM MgCI2, 1 mM EDTA, 0.2% BSA, 
0.5 mM ascorbic acid, 0.5 mM adenyl-5-yl-imidodiphosphate, 
10 nM [35S]GTPTS and 20 ~g/ml of OKT3 as indicated. The 
reaction was started by the addition of 50/~g membrane protein 
and stopped by the addition of 450/@1 of icecold stopbuffer con- 
taining 10 mM Tris (pH 7.4), 100 mM NaC1 and 25/zM 
GTPTS. Bound ligand was separated from free by filtration 
through Whatman GF/C filters with icecold stopbuffer without 
GTPTS. 
2.5. Toxin treatment of  Jurkat membranes 
Pertussis toxin and cholera toxin were preactivated with 
15 mM dithiothreitol at 37°C for 30 min. The membranes 
(2 mg/ml) were then treated with either 25/zg/ml of pertussis 
toxin or 50/~g/ml of cholera toxin in 0.15 M potassium 
phosphate (pH 7.5), 1 mM NAD, 0.5 mM ATP, 10mM 
thymidine and 50 :M GTP at 30°C for 30 rain. Following treat- 
ment he membranes were resuspended in 10 mM Tris (pH 7.6) 
and kept on ice until used. 
3. RESULTS AND DISCUSSION 
Receptor-mediated activation of a G-protein 
regulated effector system is initiated by the re- 
placement of bound GDP by GTP  [14] and also 
associated with the activation of a high aff inity 
GTPase as originally shown for adenylate cyclase 
[15]. Therefore, in order to obtain direct evidence 
for regulation of a G-protein by the CD3/T-cel l  
receptor complex we have examined the effect of 
CD3 stimulation on GTPase activity in Jurkat 
membranes.  
A significant GTP  hydrolysis activity is present 
in control Jurkat membranes.  St imulation with 
OKT3 was found to increase GTP  hydrolysis by 
50% (f ig. l)  whereas st imulation with a nonac-  
t ivating anti-CD4 ant ibody did not affect the 
hydrolysis (not shown). Hydrolysis was linear 
throughout the 15 min interval as described before 
[16]. The maximal hydrolysis rate was 3.7 pmol 
per mg membrane protein min -  t which is similar to 
the activity described in $49 lymphoma cells [17] 
but significantly lower than reported in CT6 T- 
cells [16]. The reason for this difference is unclear 
but may reflect a relatively low G-protein content 
in Jurkat membranes.  It should also be noted that 
crude membrane preparations as used here and by 
others [16,17] contain a substantial amount  of 
mitochondr ia making our estimation only relative. 
A dose-response curve shows that the increase in 
GTP  hydrolysis was half maximal at an ant ibody 
concentrat ion of 2.8/zg/ml (fig.2). This is com- 
parable with ant ibody concentrations sufficient for 
Ca 2+ influx and inositol phosphate formation in T- 
lymphocytes [ 11,18]. 
GDP inhibits GTP  hydrolysis by competing with 
GTP  binding [14]. GDP was found to inhibit 
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Fig.1. Stimulation of [7-3zP]GTP hydrolysis by OKT3. Jurkat 
membranes (20 #g) were incubated with 100 nM [y-32P]GTP at 
30°C for the indicated times in the presence (closed circle) and 
absence (open circle) of 20/~g/ml of OKT3. GTP hydrolysis 
was determined asthe release of 32Pi. Each point is the mean 
of triplicate determinations. Standard eviations were less than 
10%. The result is representative of five experiments. 
100 
0 
so 
OC; 
0 
0 
C 
i , | | 
10 20 30 40 
OKT 3 (/zg/rnl) 
Fig.2. Hydrolysis of [7-32P]GTP at different concentrations of 
OKT3. Jurkat membranes (20 #g) were incubated with 100 nM 
[7-3zP]GTP at 30°C for 10 min with the indicated concentra- 
tions of OKT3. Each point is the mean of triplicate deter- 
minations. Standard eviations were less than 10g0. The result 
is representative of two experiments. 
OKT3 stimulated GTP hydrolysis (fig.3) whereas 
ADP did not (not shown). A half-maximal inhibi- 
tion was seen at 19 #M of GDP. 
Several G-proteins, including Go and Gi, are 
substrates for pertussis toxin catalyzed ADP- 
ribosylation that inhibits the G-protein [14]. I f  the 
CD3/T-cell receptor coupled G-protein is similarly 
pertussis toxin-sensitive, one would expect hat ef- 
fects induced by CD3 stimulation should be in- 
hibited by toxin pretreatment. Pertussis toxin has 
been reported to inhibit CD3-stimulated Ca 2+ in- 
flux [8,19]. However, others have reported that 
pertussis toxin affects PLC by a mechanism 
distinct from direct G-protein inhibition in T- 
lymphocytes [20]. Our data do not support he in- 
volvement of a pertussis toxin-sensitive G-protein 
in CD3/T-cell receptor signalling (table 1). Pre- 
treatment of Jurkat membranes with 25 #g/ml  of 
pertussis toxin did not inhibit OKT3 stimulated 
GTP hydrolysis although we have found pertussis 
toxin substrates of molecular masses between 39 
and 41 kDa using ADP-ribosylation in Jurkat 
membranes (not shown). In pertussis toxin-sen- 
sitive systems a significant inhibition of agonist- 
stimulated GTPase activity has been detected at 
toxin concentrations of 10 #g/ml  [17]. We have 
also not been able to inhibit either OKT3-stimu- 
lated inositol phosphate turnover or GTPase ac- 
tivity when preincubating intact Jurkat cells with 
pertussis toxin for 20 h (not shown). We have 
found that also cholera toxin stimulates ADP-ribo- 
sylation in Jurkat membranes as well as increases 
the formation of cAMP in intact cells (not shown). 
However, pretreatment of Jurkat membranes with 
50#g/ml  of cholera toxin did not affect 
OKT3-stimulated GTP hydrolysis. This is in ap- 
parent contrast with a previous report showing 
that cholera toxin inhibits Ca 2+ influx and IP3 for- 
mation in Jurkat cells [9]. However, the cholera 
toxin-induced activation of G,-proteins leads to an 
increased formation of cAMP which could affect 
IP3 formation at a step subsequent o the G- 
protein as recently reported [21]. The toxin pre- 
treatment caused a slight increase in basal and 
stimulated GTPase activity. This may be due to the 
membrane binding and mitogenic effect of these 
toxins [22,23]. However, pretreatment of intact 
cells or short term membrane stimulation did not 
cause an increased GTPase activity (not shown) 
making this explanation unlikely. 
In order to substantiate further the association 
of a G-protein to the CD3/T-cell receptor we 
analyzed the binding of the nonhydrolysable GTP 
analogue GTPyS to Jurkat membranes after 
stimulation with OKT3. We found that OKT3 
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Fig.3. Inhibition of OKT3-stimulated hydrolysis of [-r-SzP]GTP 
by GDP. Jurkat membranes (20#g) were incubated with 
100 nM [y-32p]GTP at 30°C for 10 rain with the indicated 
concentrations of GDP and 20 #g/ml of OKT3. Each point is 
the mean of triplicate determinations. Standard eviations were 
less than 10070. The result is representative of two experiments. 
causes a minor,  but statistically significant, in- 
crease in the binding of GTPyS by approximately 
20°70 (rigA). This is in line with the st imulation of 
GTPyS  binding in HL-60 cells by fMLP [4]. In 
contrast o CT6 cells [17], GTPvS  binding did not 
reach equi l ibr ium within the 10min  period 
studied. Instead incubations for as long as 60 min 
Table 1 
Effect of pretreatment of membranes with pertussis or cholera 
toxin 
Pretreatment Stimulation GTPase activity 
(pmol/mg per 10 min) 
- - 17.8 +_ 1.1 
- OKT3 26.6 ± 0.5 
PTX - 21.2 ± 0.4 
PTX OKT3 31.8 ± 0.7 
CT - 23.7 ± 2.0 
CT OKT3 32.0 ± 1.2 
Effect of pertussis toxin and cholera toxin on OKT3-stimulated 
hydrolysis of [y-32PlGTP. Jurkat membranes were pretreated 
with 25 #g/ml of pertussis toxin or 50 #g/ml of cholera toxin at 
30°C for 30 min. The membranes were then resuspended and 
analyzed for GTPase activity in the presence or absence of 
20 #g/ml of OKT3. The results are expressed asmean _+ SE of 
triplicate determinations. The result is representative of three 
experiments 
~rne (min) 
Fig.4. Stimulation of [3sS]GTPTS binding by OKT3. Jurkat 
membranes (50#g) were incubated with 10 nM [35S]GTPyS 
(106 cpm) at 30°C with (closed circles) or without (open circles) 
20#g/ml of OKT3 for the indicated times. Binding of 
[3sSIGTPyS was measured as described in section 2. Non- 
specific binding was less than 10070 in all determinations. Each 
point is the mean of triplicate determinations. Standard 
deviations were less than 10070. * and ** indicate statistical 
significance (p< 0.1 and p < 0.05 by a two-tailed Student's t-
test). The result is representative of three experiments. 
were necessary for equi l ibr ium (not shown). This is 
compatible with a lower rate of GTP  turnover in 
Jurkat cells and agrees with the already noted 
lower GTPase activity. 
Our  data suggest he involvement of a pertussis 
toxin- and cholera toxin-insensitive G-protein in 
signall ing via the CD3/T-cel l  receptor complex. It 
seems likely that this G-protein is of the Gp type 
since it is toxin insensitive and associated with a 
phospholipase C l inked receptor. The product of 
the growth-promoting ras-protein has been pro- 
posed to be a PLC coupled G-protein [24]. It is an 
intr iguing possibil ity that the G-protein involved in 
CD3/T-cel l  receptor signalling may be similar to 
p21 raS. 
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